Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
In order to isolate the precursor from blood, we synthesized an affinity sorbent with cross-linked 25-hydroxy vitamin D3 and developed a chromatography procedure that differed completely from the method described previously in ref. [35]. 25-OH-D3/Sepharose® turned out to be a stable substrate enabling up to nine chromatography runs and even more per portion of resin.
Source: 3.1. Differences in DBPs Isolated Using the Actin/chitin and 25-OH-D3/Sepharose® Affinity Sorbents, Tandem Mass Spectrometry Analysis of the Two Fractions Isolated Using 25-OH-D3/Sepharose®. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Therefore, the model for assessing the synthesis of pro-inflammatory mediators TNF-α and IL-1β and the major anti-inflammatory cytokines TGF-β and IL-10 by peritoneal macrophages isolated from C57BL/6 mice was chosen to analyze the activating ability of DBP and GcMAF.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The Molecular Aspects of Functional Activity of Macrophage-Activating Factor GcMAF
Study design awaiting verification · International Journal of Molecular Sciences · 2023
Original publication title
The Molecular Aspects of Functional Activity of Macrophage-Activating Factor GcMAF
© 2023 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Group-specific component macrophage-activating factor (GcMAF) is the vitamin D3-binding protein (DBP) deglycosylated at Thr420. The protein is believed to exhibit a wide range of therapeutic properties associated with the activation of macrophagal immunity. An original method for GcMAF production, DBP conversion to GcMAF, and the analysis of the activating potency of GcMAF was developed in this study. Data unveiling the molecular causes of macrophage activation were obtained. GcMAF was found to interact with three CLEC10A derivatives having molecular weights of 29 kDa, 63 kDa, and 65 kDa.
GcMAF interacts with high-molecular-weight derivatives via Ca2+-dependent receptor engagement. Binding to the 65 kDa or 63 kDa derivative determines the pro: and anti-inflammatory direction of cytokine mRNA expression: 65 kDa: pro-inflammatory (TNF-α, IL-1β) and 63 kDa: anti-inflammatory (TGF-β, IL-10). No Ca2+ ions are required for the interaction with the canonical 29 kDa CLEC10A. Both forms, DBP protein and GcMAF, bind to the 29 kDa CLEC10A. This interaction is characterized by the stochastic mRNA synthesis of the analyzed cytokines. Ex vivo experiments have demonstrated that when there is an excess of GcMAF ligand, CLEC10A forms aggregate, and the mRNA synthesis of analyzed cytokines is inhibited.
A schematic diagram of the presumable mechanism of interaction between the CLEC10A derivatives and GcMAF is provided. The principles and elements of standardizing the GcMAF preparation are elaborated.
Authors’ abstract
Group-specific component macrophage-activating factor (GcMAF) is the vitamin D3-binding protein (DBP) deglycosylated at Thr420. The protein is believed to exhibit a wide range of therapeutic properties associated with the activation of macrophagal immunity. An original method for GcMAF production, DBP conversion to GcMAF, and the analysis of the activating potency of GcMAF was developed in this study. Data unveiling the molecular causes of macrophage activation were obtained. GcMAF was found to interact with three CLEC10A derivatives having molecular weights of 29 kDa, 63 kDa, and 65 kDa.
GcMAF interacts with high-molecular-weight derivatives via Ca2+-dependent receptor engagement. Binding to the 65 kDa or 63 kDa derivative determines the pro: and anti-inflammatory direction of cytokine mRNA expression: 65 kDa: pro-inflammatory (TNF-α, IL-1β) and 63 kDa: anti-inflammatory (TGF-β, IL-10). No Ca2+ ions are required for the interaction with the canonical 29 kDa CLEC10A. Both forms, DBP protein and GcMAF, bind to the 29 kDa CLEC10A. This interaction is characterized by the stochastic mRNA synthesis of the analyzed cytokines. Ex vivo experiments have demonstrated that when there is an excess of GcMAF ligand, CLEC10A forms aggregate, and the mRNA synthesis of analyzed cytokines is inhibited.
A schematic diagram of the presumable mechanism of interaction between the CLEC10A derivatives and GcMAF is provided. The principles and elements of standardizing the GcMAF preparation are elaborated.
Publication and source details
Original title: The Molecular Aspects of Functional Activity of Macrophage-Activating Factor GcMAF
Svetlana S. Kirikovich; Evgeniy V. Levites; Anastasia S. Proskurina; Genrikh S. Ritter; Sergey E. Peltek; Asya R. Vasilieva; Vera S. Ruzanova; Evgeniya V. Dolgova; Sofya G. Oshihmina; Alexandr V. Sysoev; Danil I. Koleno; Elena D. Danilenko; Oleg S. Taranov; Alexandr A. Ostanin; Elena R. Chernykh; Nikolay A. Kolchanov; Sergey S. Bogachev
International Journal of Molecular Sciences · 2023
* Correspondence: svetak@bionet.nsc.ru (S.S.K.); labmolbiol@mail.ru (S.S.B.); Tel.: +7-(383)-363-49-63 (ext. 3411) (S.S.K.)These authors contributed equally to this work.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T05:37:29.871747+00:00
DOI: 10.3390/ijms242417396 · PMC10743851